Vivaldi Capital Management LP Indaptus Therapeutics, Inc. Transaction History
Vivaldi Capital Management LP
- $609 Million
- Q1 2025
A detailed history of Vivaldi Capital Management LP transactions in Indaptus Therapeutics, Inc. stock. As of the latest transaction made, Vivaldi Capital Management LP holds 24,000 shares of INDP stock, worth $282,480. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,000
Previous 24,000
-0.0%
Holding current value
$282,480
Previous $20,000
35.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding INDP
# of Institutions
18Shares Held
687KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA256KShares$3.02 Million0.0% of portfolio
-
Investment House LLC Las Vegas, NV129KShares$1.52 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA125KShares$1.47 Million0.0% of portfolio
-
Strategy Asset Managers LLC45.3KShares$533,6040.0% of portfolio
-
Pine Valley Investments LTD Liability CO Marlton, NJ43.9KShares$516,9500.0% of portfolio
About Indaptus Therapeutics, Inc.
- Ticker INDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,258,600
- Market Cap $97.2M
- Description
- Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...